CAS 823178-43-4
:Anagrelide hcl monohydrate
Description:
Anagrelide hydrochloride monohydrate is a pharmaceutical compound primarily used as a platelet-reducing agent in the treatment of essential thrombocythemia, a condition characterized by an overproduction of platelets. It functions as a selective inhibitor of megakaryocyte maturation, thereby reducing platelet counts in the bloodstream. The substance appears as a white to off-white crystalline powder and is soluble in water, which facilitates its administration in a clinical setting. Its chemical structure includes a pyrimidinone core, contributing to its biological activity. Anagrelide is typically administered orally, and its pharmacokinetics involve metabolism primarily in the liver, with renal excretion of its metabolites. Common side effects may include headache, palpitations, and gastrointestinal disturbances. As with any medication, it is essential to monitor patients for potential adverse reactions and interactions with other drugs. Overall, Anagrelide hydrochloride monohydrate plays a crucial role in managing conditions associated with elevated platelet levels, improving patient outcomes when used appropriately.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Anagrelide Hydrochloride
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C10H7Cl2N3O·HCl·H2OColor and Shape:Off-White White PowderMolecular weight:254.996626,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one hydrochloride hydrate
CAS:6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one hydrochloride hydratePurity:98%Molecular weight:310.57g/molAnagrelide hydrochloride monohydrate
CAS:Anagrelide HCl monohydrate is a platelet-reducing imidazoquinazoline for ET and PV research.Formula:C10H10Cl3N3O2Color and Shape:SolidMolecular weight:310.56Anagrelide Hydrochloride Monohydrate
CAS:Controlled ProductFormula:C10H7Cl2N3O·ClH·H2OColor and Shape:NeatMolecular weight:310.564Anagrelide hydrochloride monohydrate
CAS:Anagrelide hydrochloride monohydrate is a synthetic drug that has been shown to be effective in the treatment of cardiovascular diseases and myeloproliferative disorder. It is also used as a prophylactic agent for thromboembolic disorders. Anagrelide hydrochloride monohydrate is used to prevent complications when patients are undergoing surgery, or are at risk for developing deep vein thrombosis or pulmonary embolism. The dosage range is usually between 0.2mg/kg and 1mg/kg, with an average dose of 0.5 mg/kg. In some cases, doses may be increased to 2 mg/kg, if needed. Anagrelide hydrochloride monohydrate belongs to the class of drugs known as phosphodiesterase inhibitors that work by preventing the breakdown of cyclic AMP (cAMP). Anagrelide hydrochloride monohydrate also inhibits the activity of cyclic GMP phosphodiesterase, whichFormula:C10H7Cl2N3O•HCl•H2OPurity:Min. 95%Molecular weight:310.56 g/mol





